These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1321340)

  • 1. pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells.
    Zhou R; Daar I; Ferris DK; White G; Paules RS; Vande Woude G
    Mol Cell Biol; 1992 Aug; 12(8):3583-9. PubMed ID: 1321340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the c-mos product to associate with and phosphorylate tubulin.
    Zhou RP; Oskarsson M; Paules RS; Schulz N; Cleveland D; Vande Woude GF
    Science; 1991 Feb; 251(4994):671-5. PubMed ID: 1825142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p34cdc2 protein is complexed with the c-mos protein in rat skeletal muscle.
    Leibovitch SA; Guillier M; Lenormand JL; Leibovitch MP
    Oncogene; 1993 Sep; 8(9):2361-9. PubMed ID: 8395677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characterization of pp39mos association with tubulin.
    Zhou RP; Shen RL; Pinto da Silva P; Vande Woude GF
    Cell Growth Differ; 1991 May; 2(5):257-65. PubMed ID: 1832292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk.
    Bai W; Singh B; Yang Y; Arlinghaus RB
    Oncogene; 1992 Sep; 7(9):1757-63. PubMed ID: 1323818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2.
    Azzi L; Meijer L; Reed SI; Pidikiti R; Tung HY
    Eur J Biochem; 1992 Feb; 203(3):353-60. PubMed ID: 1310466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p13suc1 suppresses the catalytic function of p34cdc2 kinase for intermediate filament proteins, in vitro.
    Kusubata M; Tokui T; Matsuoka Y; Okumura E; Tachibana K; Hisanaga S; Kishimoto T; Yasuda H; Kamijo M; Ohba Y
    J Biol Chem; 1992 Oct; 267(29):20937-42. PubMed ID: 1400409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of a histone H1 kinase by tyrosine phosphorylation in v-src-transformed fibroblasts.
    Sternberg DW; Scholz G; Fukui Y; Hanafusa H
    EMBO J; 1993 Jan; 12(1):323-30. PubMed ID: 7679071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways.
    Barrett CB; Schroetke RM; Van der Hoorn FA; Nordeen SK; Maller JL
    Mol Cell Biol; 1990 Jan; 10(1):310-5. PubMed ID: 2152963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells.
    Daar I; Paules RS; Vande Woude GF
    J Cell Biol; 1991 Jul; 114(2):329-35. PubMed ID: 1830055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cdc2-like kinase associated with commitment to division in Paramecium tetraurelia.
    Tang L; Pelech SL; Berger JD
    J Eukaryot Microbiol; 1994; 41(4):381-7. PubMed ID: 8087107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
    Rhodes N; Innes CL; Propst F; Paules RS
    Oncogene; 1997 Jun; 14(25):3017-27. PubMed ID: 9223665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF
    Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
    J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokinin controls the cell cycle at mitosis by stimulating the tyrosine dephosphorylation and activation of p34cdc2-like H1 histone kinase.
    Zhang K; Letham DS; John PC
    Planta; 1996; 200(1):2-12. PubMed ID: 8987615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates.
    Norbury C; Blow J; Nurse P
    EMBO J; 1991 Nov; 10(11):3321-9. PubMed ID: 1655417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210.
    Hamaguchi JR; Tobey RA; Pines J; Crissman HA; Hunter T; Bradbury EM
    J Cell Biol; 1992 Jun; 117(5):1041-53. PubMed ID: 1533642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential occurrence of CSF-like activity and transforming activity of Mos during the cell cycle in fibroblasts.
    Okazaki K; Nishizawa M; Furuno N; Yasuda H; Sagata N
    EMBO J; 1992 Jul; 11(7):2447-56. PubMed ID: 1385775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of a 15-kDa cdk4- and cdk5-binding protein.
    Azzi L; Meijer L; Ostvold AC; Lew J; Wang JH
    J Biol Chem; 1994 May; 269(18):13279-88. PubMed ID: 8175758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases.
    Cheng HC; Nishio H; Hatase O; Ralph S; Wang JH
    J Biol Chem; 1992 May; 267(13):9248-56. PubMed ID: 1577758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.